Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Re: Arinobu Fukunaga, Takahisa Kawaguchi, Satoshi Funada, et al. Sleep Disturbance Worsens Lower Urinary Tract Symptoms (LUTS): The Nagahama Study. J Urol. In press. https://doi.org/10.1097/JU.0000000000000212: Relationship between sleep disturbance and low urinary tract symptoms: "Shallow Medicine".

Misraï V, Charbonneau H, Pathak A, Louvrier C, Maldent JB, Milioto O, Attias D, Aranda A.

Eur Urol Focus. 2019 Jun 11. pii: S2405-4569(19)30155-5. doi: 10.1016/j.euf.2019.05.018. [Epub ahead of print] No abstract available.

PMID:
31201082
3.

The safety of lasers for BPH surgery in men taking clopidogrel: one cannot judge a book by its cover.

Misraï V, Zorn KC, Peyronnet B, Charbonneau H, Pathak A.

World J Urol. 2019 Feb 23. doi: 10.1007/s00345-019-02685-y. [Epub ahead of print] No abstract available.

PMID:
30798380
4.

Stopping or maintaining oral anticoagulation in patients undergoing photoselective vaporization of the prostate (SOAP) surgery for benign prostate obstruction: study protocol for a multicentre randomized controlled trial.

Charbonneau H, Pasquié M, Peyronnet B, Descazeaud A, Barry-Delongchamps N, Della Negra E, Mathieu R, Karsenty G, Long JA, Ballereau C, Azzouzi AR, Pradère B, Bruyère F, Fournier G, Lebdai S, Calves J, Corbel L, Vincendeau S, Fiard G, Thuillier C, Descotes JL, Colin P, Culty T, Hesbois A, Fuzier V, Savy N, Pathak A, Albaladejo P, Samama CM, Guerrero F, Misraï V.

Trials. 2018 Dec 27;19(1):705. doi: 10.1186/s13063-018-3066-9.

5.

Relationship between nocturia and mortality: are we missing the forest for the trees?

Misraï V, Peyronnet B, Charbonneau H, Attias D, Pathak A.

Prostate Cancer Prostatic Dis. 2019 Mar;22(1):3-4. doi: 10.1038/s41391-018-0115-0. Epub 2018 Nov 28. No abstract available.

PMID:
30487645
6.

Obstructive sleep apnea syndrome should always be screened in patients complaining of nocturia.

Misraï V, Charbonneau H, Attias D, Pathak A.

World J Urol. 2018 Oct 22. doi: 10.1007/s00345-018-2534-x. [Epub ahead of print] No abstract available.

PMID:
30350015
7.

Icatibant as an early rescue therapy in hypovolemic shock with converting enzyme inhibitor treatment.

Charbonneau H, Buléon M, Richard B, Mayeur N.

Crit Care. 2017 Nov 2;21(1):271. doi: 10.1186/s13054-017-1857-0. No abstract available.

8.

A Substrate Trapping Method for Identification of Direct Cdc14 Phosphatase Targets.

Powers BL, Hall H, Charbonneau H, Hall MC.

Methods Mol Biol. 2017;1505:119-132.

PMID:
27826861
9.

Acute Bradykinin Receptor Blockade During Hemorrhagic Shock in Mice Prevents the Worsening Hypotensive Effect of Angiotensin-Converting Enzyme Inhibitor.

Charbonneau H, Buléon M, Minville V, Faguer S, Girolami JP, Bascands JL, Tack I, Mayeur N.

Crit Care Med. 2016 Sep;44(9):e882-5. doi: 10.1097/CCM.0000000000001646.

PMID:
26992065
10.

Greenlight™ photovaporization of the prostate in patients under rivaroxaban: Lesson learned after the first cases.

Charbonneau H, Pathak A, Albenque JP, Misrai V.

Prog Urol. 2016 Apr;26(5):273-5. doi: 10.1016/j.purol.2016.02.002. Epub 2016 Mar 9. No abstract available.

PMID:
26970929
11.

The cost of decontaminating an ED after finding a bed bug: results from a single academic medical center.

Totten V, Charbonneau H, Hoch W, Shah S, Sheele JM.

Am J Emerg Med. 2016 Mar;34(3):649. doi: 10.1016/j.ajem.2015.12.020. Epub 2015 Dec 14. No abstract available.

PMID:
26783149
12.

Measuring Activity and Specificity of Protein Phosphatases.

Powers BL, Melesse M, Eissler CL, Charbonneau H, Hall MC.

Methods Mol Biol. 2016;1342:221-35. doi: 10.1007/978-1-4939-2957-3_13.

PMID:
26254927
13.

Predicting preload responsiveness using simultaneous recordings of inferior and superior vena cavae diameters.

Charbonneau H, Riu B, Faron M, Mari A, Kurrek MM, Ruiz J, Geeraerts T, Fourcade O, Genestal M, Silva S.

Crit Care. 2014 Sep 5;18(5):473. doi: 10.1186/s13054-014-0473-5.

14.

Bleeding complications in patients with coronary stents during non-cardiac surgery.

Albaladejo P, Charbonneau H, Samama CM, Collet JP, Marret E, Piriou V, Genty C, Bosson JL.

Thromb Res. 2014 Aug;134(2):268-72. doi: 10.1016/j.thromres.2014.05.015. Epub 2014 May 15.

PMID:
24913999
15.

Mediastinitis due to Gram-negative bacteria is associated with increased mortality.

Charbonneau H, Maillet JM, Faron M, Mangin O, Puymirat E, Le Besnerais P, Du Puy-Montbrun L, Achouh P, Diehl JL, Fagon JY, Mainardi JL, Guerot E.

Clin Microbiol Infect. 2014 Mar;20(3):O197-202. doi: 10.1111/1469-0691.12369. Epub 2013 Oct 30.

16.

Cdc14 phosphatases preferentially dephosphorylate a subset of cyclin-dependent kinase (Cdk) sites containing phosphoserine.

Bremmer SC, Hall H, Martinez JS, Eissler CL, Hinrichsen TH, Rossie S, Parker LL, Hall MC, Charbonneau H.

J Biol Chem. 2012 Jan 13;287(3):1662-9. doi: 10.1074/jbc.M111.281105. Epub 2011 Nov 23.

17.

A general strategy for studying multisite protein phosphorylation using label-free selected reaction monitoring mass spectrometry.

Eissler CL, Bremmer SC, Martinez JS, Parker LL, Charbonneau H, Hall MC.

Anal Biochem. 2011 Nov 15;418(2):267-75. doi: 10.1016/j.ab.2011.07.015. Epub 2011 Jul 22.

18.

Non-cardiac surgery in patients with coronary stents: the RECO study.

Albaladejo P, Marret E, Samama CM, Collet JP, Abhay K, Loutrel O, Charbonneau H, Jaber S, Thoret S, Bosson JL, Piriou V.

Heart. 2011 Oct;97(19):1566-72. doi: 10.1136/hrt.2011.224519. Epub 2011 Jul 26.

PMID:
21791513
19.

A crackling priapism related to Fournier's gangrene in a patient on chronic peritoneal dialysis.

Charbonneau H, Pène F.

J Infect. 2010 Sep;61(3):274-5. doi: 10.1016/j.jinf.2010.06.011. Epub 2010 Jun 22. No abstract available.

PMID:
20600298
20.

[What is the outcome of cardiac arrest survivors?].

Fichet J, Dumas F, Charbonneau H, Giovanetti O, Cariou A.

Presse Med. 2010 Jun;39(6):694-700. doi: 10.1016/j.lpm.2010.02.042. French.

PMID:
20399598
21.

Early use of lipid emulsion to treat incipient mepivacaine intoxication.

Charbonneau H, Marcou TA, Mazoit JX, Zetlaoui PJ, Benhamou D.

Reg Anesth Pain Med. 2009 May-Jun;34(3):277-8. doi: 10.1097/AAP.0b013e31819340be. No abstract available.

PMID:
19436188
22.

Cdc28 and Cdc14 control stability of the anaphase-promoting complex inhibitor Acm1.

Hall MC, Jeong DE, Henderson JT, Choi E, Bremmer SC, Iliuk AB, Charbonneau H.

J Biol Chem. 2008 Apr 18;283(16):10396-407. doi: 10.1074/jbc.M710011200. Epub 2008 Feb 20.

23.

Inactivation of Apc in the mouse prostate causes prostate carcinoma.

Bruxvoort KJ, Charbonneau HM, Giambernardi TA, Goolsby JC, Qian CN, Zylstra CR, Robinson DR, Roy-Burman P, Shaw AK, Buckner-Berghuis BD, Sigler RE, Resau JH, Sullivan R, Bushman W, Williams BO.

Cancer Res. 2007 Mar 15;67(6):2490-6.

24.

Kinetic and mechanistic studies of a cell cycle protein phosphatase Cdc14.

Wang WQ, Bembenek J, Gee KR, Yu H, Charbonneau H, Zhang ZY.

J Biol Chem. 2004 Jul 16;279(29):30459-68. Epub 2004 May 5.

25.

Disruption of centrosome structure, chromosome segregation, and cytokinesis by misexpression of human Cdc14A phosphatase.

Kaiser BK, Zimmerman ZA, Charbonneau H, Jackson PK.

Mol Biol Cell. 2002 Jul;13(7):2289-300.

26.

Cdc5 influences phosphorylation of Net1 and disassembly of the RENT complex.

Shou W, Azzam R, Chen SL, Huddleston MJ, Baskerville C, Charbonneau H, Annan RS, Carr SA, Deshaies RJ.

BMC Mol Biol. 2002 Apr 17;3:3. Epub 2002 Apr 17.

27.

Net1 stimulates RNA polymerase I transcription and regulates nucleolar structure independently of controlling mitotic exit.

Shou W, Sakamoto KM, Keener J, Morimoto KW, Traverso EE, Azzam R, Hoppe GJ, Feldman RM, DeModena J, Moazed D, Charbonneau H, Nomura M, Deshaies RJ.

Mol Cell. 2001 Jul;8(1):45-55.

28.

Characterization of the Net1 cell cycle-dependent regulator of the Cdc14 phosphatase from budding yeast.

Traverso EE, Baskerville C, Liu Y, Shou W, James P, Deshaies RJ, Charbonneau H.

J Biol Chem. 2001 Jun 15;276(24):21924-31. Epub 2001 Mar 27.

29.

Human sex ratio at birth and mother's birth season: multivariate analysis.

Nonaka K, Desjardins B, Charbonneau H, Légaré J, Miura T.

Hum Biol. 1999 Oct;71(5):875-84.

PMID:
10510576
30.

The tetratricopeptide repeat domain and a C-terminal region control the activity of Ser/Thr protein phosphatase 5.

Sinclair C, Borchers C, Parker C, Tomer K, Charbonneau H, Rossie S.

J Biol Chem. 1999 Aug 13;274(33):23666-72.

31.

Human PIR1 of the protein-tyrosine phosphatase superfamily has RNA 5'-triphosphatase and diphosphatase activities.

Deshpande T, Takagi T, Hao L, Buratowski S, Charbonneau H.

J Biol Chem. 1999 Jun 4;274(23):16590-4.

32.

Exit from mitosis is triggered by Tem1-dependent release of the protein phosphatase Cdc14 from nucleolar RENT complex.

Shou W, Seol JH, Shevchenko A, Baskerville C, Moazed D, Chen ZW, Jang J, Shevchenko A, Charbonneau H, Deshaies RJ.

Cell. 1999 Apr 16;97(2):233-44.

33.
34.

A protein tyrosine phosphatase-like protein from baculovirus has RNA 5'-triphosphatase and diphosphatase activities.

Takagi T, Taylor GS, Kusakabe T, Charbonneau H, Buratowski S.

Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):9808-12.

35.

High refractive errors and the accident/incident rate in Canadian medical category 1 pilots.

Wallace JM, Liddy B, Charbonneau H, Balfour D, Wielgosz A.

Aviat Space Environ Med. 1997 Nov;68(11):1050-1.

PMID:
9383508
36.
37.
38.

Purification of a fatty acid-stimulated protein-serine/threonine phosphatase from bovine brain and its identification as a homolog of protein phosphatase 5.

Skinner J, Sinclair C, Romeo C, Armstrong D, Charbonneau H, Rossie S.

J Biol Chem. 1997 Sep 5;272(36):22464-71.

39.

Season of birth and Alzheimer's disease: a population-based study in Saguenay-Lac-St-Jean/Québec (IMAGE Project).

Vézina H, Houde L, Charbonneau H, Beaudry M, Cholette A, Daoud N, Mathieu J, Robitaille Y, Veilleux F, Gauvreau D.

Psychol Med. 1996 Jan;26(1):143-9.

PMID:
8643753
40.

Identification of inhibitory and calmodulin-binding domains of the PDE1A1 and PDE1A2 calmodulin-stimulated cyclic nucleotide phosphodiesterases.

Sonnenburg WK, Seger D, Kwak KS, Huang J, Charbonneau H, Beavo JA.

J Biol Chem. 1995 Dec 29;270(52):30989-1000.

41.

Slow twin conception at first birth and subsequent maternal twin proneness in a natural fertility population.

Nonaka K, Desjardins B, Charbonneau H, Légaré J, Miura T.

Acta Genet Med Gemellol (Roma). 1995;44(3-4):215-22.

PMID:
8739733
43.

Reproductive life of French-Canadians in the 17-18th centuries: a search for a trade-off between early fecundity and longevity.

Le Bourg E, Thon B, Légaré J, Desjardins B, Charbonneau H.

Exp Gerontol. 1993 May-Jun;28(3):217-32.

PMID:
8344394
44.

The baculovirus Autographa californica encodes a protein tyrosine phosphatase.

Sheng Z, Charbonneau H.

J Biol Chem. 1993 Mar 5;268(7):4728-33.

45.

Molecular cloning of cDNA encoding a "63"-kDa calmodulin-stimulated phosphodiesterase from bovine brain.

Bentley JK, Kadlecek A, Sherbert CH, Seger D, Sonnenburg WK, Charbonneau H, Novack JP, Beavo JA.

J Biol Chem. 1992 Sep 15;267(26):18676-82.

46.

Primary structure and functional expression of the beta 1 subunit of the rat brain sodium channel.

Isom LL, De Jongh KS, Patton DE, Reber BF, Offord J, Charbonneau H, Walsh K, Goldin AL, Catterall WA.

Science. 1992 May 8;256(5058):839-42.

PMID:
1375395
47.

Tyrosine phosphatases and their possible interplay with tyrosine kinases.

Fischer EH, Charbonneau H, Cool DE, Tonks NK.

Ciba Found Symp. 1992;164:132-40; discussion 140-4. Review.

PMID:
1395930
48.

1002 protein phosphatases?

Charbonneau H, Tonks NK.

Annu Rev Cell Biol. 1992;8:463-93. Review. No abstract available.

PMID:
1335746
49.

Protein-tyrosine-phosphatase CD45 is phosphorylated transiently on tyrosine upon activation of Jurkat T cells.

Stover DR, Charbonneau H, Tonks NK, Walsh KA.

Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7704-7.

50.

Sequence comparison of the 63-, 61-, and 59-kDa calmodulin-dependent cyclic nucleotide phosphodiesterases.

Novack JP, Charbonneau H, Bentley JK, Walsh KA, Beavo JA.

Biochemistry. 1991 Aug 13;30(32):7940-7.

PMID:
1651112

Supplemental Content

Loading ...
Support Center